DOCSLIB.ORG

Fast Tracking of Hospital Medicine - Learn More About Nomeco’S New ’Minibar Concept’

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fast Tracking of Hospital Medicine - Learn More About Nomeco’S New ’Minibar Concept’ Flow No. 1 - April 2011 PharmaGolf 2011 Register now! Fast tracking of hospital medicine - learn more about Nomeco’s new ’minibar concept’. 1 Easy access at the hospital Publisher: Nomeco HealthCare Logistics - Borgmester Christiansens Gade 40 - 1790 Copenhagen V - Phone +45 36 45 45 36 - www.nomeco.dk Editor-in-chief: Henrik Kaastrup - Director, Nomeco HealthCare Logistics Editor: Christel Gørtz - Market Coordinator Layout: Christa Job Impression: 800 copies Printing: Kandrups Bogtrykkeri A/S New initiative from the Ministry of Health Nomeco on site stock By Henrik Kaastrup, Director Nomeco HealthCare Logistics - Availability in focus 3 As most of you know, for many years there has been a constant pressure from politicians to liberalise the pharmaceutical sector in Denmark. The Competition Authority has led the way to end the pharmacy monopoly and thus creates more competition in the sector. The brand new concept Of course, based on the strong belief that ‘Nomeco on site stock’ increasing competition automatically will lead to increased efficiency and lower prices. connects the industry directly with the hospital The past year has been no exception. Last fall the Ministry of Interior Column 2 and Health carried out talks with various parties of the pharmaceutical pharmacy. sector, especially focused on medicine prices, delivery conditions Nomeco on site stock - Availability in focus 3 and discounts. Nomeco also participated in a couple of meetings and together with the Pharmacy Association we made suggestions Specific Pharma 6 on how to solve some of the problems of the current system - without By Merete Wagner Hoffmann changing the whole sector because of it. Optimization of inbound delivery for mutural benefit 9 Update: The work of the ministry, however, was put on hold since a Nomeco offers you a space for rent in a Tina Moltke-Leth is the new CFO in Nomeco 10 liberalisation of the pharmacy sector joined the government’s growth refrigerator physically located at the hospital stimulus package. This included a proposal to remodel the pharmacy Toys for HIV afflicted orphans 10 pharmacy – right next to where your product CO2 reduction: sector – i.e. by eliminating the equalisation scheme between Reaching the goal one year before time! 11 pharmacies. The response from the pharmacies was immediate in the is needed. Similar to the mini-bar concept in Temperature Monitoring Devices 11 form of a campaign that announced massive closures of pharmacies hotels, the hospital pharmacy can pick from PharmaGolf 2011 12 in ’Marginal Denmark’. the refrigerator when the actual need arises. Purchase of the products takes place at the However, it was never materialised. The Conservatives did not support time the products leave the refrigerator. a liberalization of the pharmacies and January 20th the proposal was removed from the growth package. But peace proved short- lived. Already one day later the Ministry of Interior and Health issued This is, in brief, the concept of the new 10 a number of amendments to current legislation for consultation. The solution called Nomeco on site stock which proposed changes are quite extensive and will affect discounts to is to be launched now. pharmacies, the pharmacy right of returning products, pharmacy purchase and stock policy and other elements, which will greatly affect the wholesalers’ operations. “The principle is that the supplier owns the product all the way through the supply chain In Nomeco it is our assessment that the proposals can’t be to the hospital stock. Products will normally implemented in the form proposed. There are simply too many be held under a consignment agreement, elements that are not feasible with the technology we have available today. Other parts of the proposals we find inappropriate - because they would lead to a sharp rise in the costs of the sector. To meet the changing times in the pharmaceutical sector Nomeco JETTE PALVAD shows the 11 agrees that some of the areas in focus in the ministry package do temperature registration on the need to be modernised. However, since the current system is highly refrigerator, which has been complex and represents a very delicate economical balance specially decorated for Nomeco among the various players in the supply chain, changes should be implemented very carefully. Even very small changes may result in on site stock. The temperature dramatic and sometimes unforeseen reactions elsewhere in the chain. logger is connected through So, as always the “Danish Model” on pharma distribution is being a wireless link to Nomeco challenged and like most of you, we are eager to see which changes who constantly monitors the will be applied this summer. Until then I hope you will enjoy reading this temperature and takes action in Photo: Lars Helmersen issue of Flow. case of alarms. Continues 2 Flow - No. 1 - April 2011 3 Products within reach Facts From a QA and legal perspective the Nomeco on site stock is considered an integrated part of Nomeco’s current facilities – consequently: The refrigerator has a physical lock and access control. The back-up system has a 24-hour technical support. • The Solution is approved by the DKMA (authorities) and is being integrated into Nomecos company approval (§39 licence) • Nomeco will perform audits of all external sites • Nomeco is responsible for quality and safety of the products • Products are insured by Nomeco • Existing import control procedures are not affected • Coldchain is unbroken from Nomeco to the external site • It has double control, documented procedures and deviation procedures often as a simple add-on to an existing pre- wholesale or wholesale agreement,” says Jette Palvad, Deputy Manager, Hospitals and Customer Service. The referigiator is completely controlled and monitored by Nomeco. Replenishment of products used will be done by Nomeco The Capital Region Pharmacy is the first one to Hospital Service. The temperature is also test the new concept, and pharmaconomist monitored by Nomeco, who also takes Dorte Klitgaard is looking forward to get a action on alarms resulting from deviations. fast and easy delivery of products, which the pharmacy does not stock. Besides that it is not “The refrigerator is secured with a lock, necessary to call Nomeco’s medicine guard if the need occurs outside normal opening hours. and only authorised personnel in the hospital pharmacy and Nomeco can access the refrigerator with a security key,” Jette Palvad explains. The hospital pharmacy saves time and money The first refrigerator is being placed at Capital Region Pharmacy and Dorte Klitgaard, Pharmaconomist and Head of outside of normal opening hours making for the hospital, the pharma companies Purchasing at the pharmacy easily sees the it unnecessary to call the medicine guard and Nomeco. The hospital saves time and advantage of having the refrigerator within from the wholesaler. This almost levels out effort, and when urgently in need of one reach: the extra work connected with finding the of the products, the pharma companies can products in the refrigerator yourself instead be sure that their products are available ”The Nomeco on site stock refrigerator of having the product “delivered” with a when needed, and Nomeco succeeds gives us the possibility of fast delivery of packing list in a box. in contributing to a faster access to products we do not stock – either because pharmacuticals”, Jette Palvad says. of a very high price combined with small or Finally, according to Dorte Klitgaard, very fluctuating consumption. It is also an there is the advantage from the pharmacy’s The project will be closely followed and advantage for short shelf-life products we perspective that it reduces the pharmacy’s examined – and hopefully the solution will consequently do not stock, but only purchase own inventory levels if an extra safety stock soon spread to more hospital pharmacies. if needed”, she says. is placed in Nomeco on site stock. “But right now we are focusing on the Capital Region Pharmacy, and we are Dorte Klitgaard also points out that there A win-win-win very keen on making this a success for all Photo: Lars Helmersen is a great advantage of being able to pick ”All in all we believe that Nomeco on parties,” she ends. the product from Nomeco on site stock site stock will be a win-win-win situation 4 Flow - No. 1 - April 2011 5 Read more on www.specificpharma.eu Specific Pharma - commitment to patients FACTS: The EU has worked on guidelines for how patients can be secured access to medicine, which due to various with special medical needs reasons is not available on the market. The current legal basis can be found in Article five in the Directive 2001/83/ EC. This EU Directive is implemented slightly differently in Specific Pharma is a access to new innovative pharmaceuticals a struggle against time, availability and the various countries within the EU – but in Denmark, the new, 100% subsidiary that can help patients with unmet medical limited sourcing possibilities. Not having the Danish Medicines Agency has chosen that the attending physician has to apply for permission to treat a patient of Nomeco, which needs. right products in time is a serious challenge to success. with a pharmaceutical that is not marketed in Denmark – focuses on unlicensed and within a very short period, the physician will normally Moreover, the transparency in the obtain permission to treat a single patient or to use the medicines as well as development of pharmaceuticals and the Another key area for Specific Pharma is pharmaceutical generally in the clinic/hospital for a 5-year pharmaceuticals for use in global approach to information via the supplying comparators for Clinical Trials period. clinical trials. internet in recent years has meant that - the need for short delivery times and patients are becoming more educated sufficient documentation are both of high about their illness and are aware of which importance for our customers.
Load more

Recommended publications
  • •Prescription Review •Medication Review
    THE USE OF CLINICAL PHARMACISTS AND PHARMACONOMIST SERVICES IN REGARDS TO RESOURCE CONSUMPTION AND MEDICATION SAFETY IN A DANISH HOSPITAL SETTING Laura Victoria Moesgaard Lech, stud.pharm, School of Pharmaceutical Sciences, Trine Rune Høgh Nielsen, cand.pharm, ph.d., Region Zealand Hospital Pharmacy, Lona Louring Christrup, cand.pharm. ph.d., School of Pharmaceutical Sciences. Denmark. BACKGROUND RESULTS Drug-Related Problems (DRPs) are factors for increased Over the course of three weeks, 157 patients were included. morbidity, mortality and costs in the health-care system. Preventing, Number of DRPs: In total, 515 DRPs were identified (bar chart). identifying and solving DRPs are therefore essential for the There was no significant statistic difference between the number of medication safety in hospital settings. Two approaches for this are DRPs identified by PMM and CPS (Mann-Whitney, p> 0.05). the use of clinical pharmacists (MSc in pharmaceuticals and post graduate courses) and pharmaconomists (3-year education in Type of DRPs: The most frequent problem in PMM and CPS were pharmaceuticals). “costs-effectiveness” and “treatment effectiveness”, respectively, accounting for more than half of all DRPs. The type of DRPs were AIM statistically significant between across all groups (χ2, p<0.05). To investigate the number, type and severity of DRPs identified by Pharmaconomist Medication Management (PMM) and Clinical Pharmacist Service (CPS), respectively. Severity: The distribution of the severity of the DRPs across the To assess the resource consumption per patient for the PMM and three groups are shown in the bar chart. The distribution of severity 2 the CPS, respectively. was significantly different across all groups (χ , p<0.05).
    [Show full text]
  • QA Coordinator in a Biotech Company Focused on the Discovery, Design and Development of Innovative Peptide-Based Medicines
    Join us for a better future Be the new QA Coordinator in a biotech company focused on the discovery, design and development of innovative peptide-based medicines Zealand Pharma A/S (Zealand) aims to become a fully integrated biotechnology company leading in delivery of specialty medicines. We are passionate about improving the quality of life for patients with metabolic and gastrointestinal diseases, and other specialty or rare disease areas with significant unmet medical needs. In the QA team, we are now looking for a new colleague to help us build and maintain the structure in our quality system and to secure follow-up activities. The position will report to VP Quality. Ensure tracking and timely follow-up on quality related documentation hereunder deviations, change controls, audits and batch related documentation Maintain and track updates to Zealand’s Quality Management System Become superuser of the Quality Module in our validated electronic system, covering change management, deviation and CAPA management and audit & vendor management Become the QA superuser of Zealand’s EDMS system Ensure routine KPI reporting to management on training, SOP finalization, and relevant Quality topics Be an active part of records management and data governance in QA Assist in the planning and follow-up of the quality audit program Managing the Quality Management Review – drive the process, compile data and prepare for routine QMR including documentation and follow-up Prepare relevant batch related documentation in connection with release. Job Profile The successful candidate will be: Pragmatic and yet with a compliant quality mindset Have high standards for ethics and integrity High degree of structural skills and ability to transform them to practical solutions Strong communication skills verbally as well as in writing Energy and drive for team results, consistent high-performer Ability to work effectively in a fast-paced environment Enjoy being in a great team and achieve things together Fluent in English (company language) and Danish.
    [Show full text]
  • LECTURE NOTES on BP 703T. PHARMACY PRACTICE
    LECTURE NOTES on BP 703T. PHARMACY PRACTICE (Theory) Unit IV a) BUDGET PREPARATION AND IMPLEMENTATION Budget preparation and its implementation are one of the important tasks of the pharmacy department of any hospital. It requires several factors into consideration like planning & strategy for maintenance and development etc. The word budget means the financial plan of a hospital for the period of a year. Budget is a quantity of plan of action and aid to the coordination and implementation of plan. DEFINITION:- Budget is described as an instrument through which hospital administration, management at the department levels and the governing bodies can review the hospital services in relationship to the prepared plan in a comprehensive and integrated form expressed in financial terms. OBJECTIVES: a) Development of standards b) Comparison of actual results with standards c) Identification of deviation or fluctuation d) Analysis of deviation e) The responsible person will use the budget f) Details to determine whether the proposal is economically feasible and realistic. g) To monitor the hospital financial activities. h) Estimate the cost of completing objectives identified in the proposal. ADVANTAGES OF PLANNING THE BUDGET: a) Develop better financial planning. b) Gives a better focus on decision making to the management. c) Effectively manage the financial aspects of the hospital d) Exposes the reasons of over expenditure e) Helps to focus on hospital priorities f) Enhance efficiency of staffs and others TYPES OF BUDGET PREPARATION: Based on the duration of budget, it can be divided in to: Short term budget (2 years) Long term budget (5 - 10 years) DIVISION OF BUDGETS: 1.
    [Show full text]
  • Pharmaceutical Interventions on Prescription Problems in a Danish Pharmacy Setting
    Int J Clin Pharm DOI 10.1007/s11096-011-9580-4 RESEARCH ARTICLE Pharmaceutical interventions on prescription problems in a Danish pharmacy setting Anton Pottega˚rd • Jesper Hallas • Jens Søndergaard Received: 29 June 2011 / Accepted: 29 October 2011 Ó Springer Science+Business Media B.V. 2011 Abstract Background International studies regarding (9.4–11.1) interventions per 1,000 prescriptions. Conclusion pharmacists’ interventions towards prescription problems We found an intervention rate substantially higher than produce highly variable results. The only peer-reviewed study reported in previous Danish studies. in a Danish setting estimated an intervention rate of 2.3 per 1,000 prescriptions. With the introduction of a new tool for Keywords Clinical pharmacy Á Denmark Á Pharmacy registration, we hypothesized that a better estimate could be practice Á Primary care Á Problem prescriptions Á obtained. Objective We aimed to produce an up-to-date Pharmacists’ interventions estimate of the extent and type of pharmacists’ interventions towards prescription problems in a Danish pharmacy setting Setting The study was conducted at Copenhagen Sønderbro Impact of findings on practice Pharmacy, a large urban 24-hour pharmacy. Method Data were collected prospectively through an electronic form. All • The number of interventions on prescriptions in Danish interventions were primarily classified as either clinical or community pharmacies, is probably significantly higher administrative in nature, and further classified in a number of than older studies indicated. pre-determined subcategories. Furthermore, information • One third of the interventions in Danish pharmacies are about age, sex, time of day, the wording of the prescription, have a clinical background. the performed intervention, the person performing the inter- • Community pharmacists in Denmark intervene mostly vention and the type of prescriber were recorded.
    [Show full text]
  • Public Health and Patient Care Aspects in Pharmacy Education and Pharmacists’ Role in National Public Health Programs in India
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Helsingin yliopiston digitaalinen arkisto Clinical Pharmacy Group: Social Pharmacy Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy University of Helsinki Public Health and Patient Care Aspects in Pharmacy Education and Pharmacists’ Role in National Public Health Programs in India Siva Prasada Reddy Maddirala Venkata ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Pharmacy of the University of Helsinki, for public examination in Auditorium Athena, Siltavuorenpenger 3 A, on Friday 19 May 2017, at 12 noon. Helsinki 2017 Supervisors Professor Marja Airaksinen, PhD Clinical Pharmacy Group: Social Pharmacy Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy, University of Helsinki Helsinki, Finland Proprietor Pharmacist Peter Kielgast, PhD Taastrup Pharmacy Taastrup Hovedgade 60 2630 Taastrup, Denmark Pre-examiners Professor B. Suresh Vice-Chancellor, Jagadguru Sri Shivarathreeshwara University and President, Pharmacy Council of India JSS Medical Institutions Campus Sri Shivarathreeshwara Nagara Mysuru – 570 015, Karnataka, India Dr. T. V. Narayana Director, Vikas Institute of Pharmaceutical Sciences Nidigatla village, Korukonda Mandal, Near Airport Rajahmundry, East Godavari Dist Andhra Pradesh – 533103, India Opponent Fernando Fernandez-Llimos, Ph.D., PharmD., M.B.A. Assistant Professor, Department of Social Pharmacy University of Lisbon, Portugal © Siva Prasada Reddy Maddirala Venkata 2017 ISBN 978-951-51-3169-0 (paperback) ISBN 978-951-51-3170-6 (PDF) Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis Helsinkiensis ISSN 2342-3161 (print) ISSN 2342-317x (online) University of Helsinki, Finland 2017 ABSTRACT Pharmacies are convenient for most people to get to and there is no need for an appointment to see pharmacist which makes them natural first port of call1 healthcare providers in the society.
    [Show full text]
  • Global Journal of Medical Research: B Pharma, Drug Discovery, Toxicology & Medicine
    Online ISSN : 2249-4618 Print ISSN : 0975-5888 DOI : 10.17406/GJMRA DrugComplianceamongPeople AntidiabeticHerbalCapsule TypesofMachineryofTranscription ADetailedReviewonPlantMaterial VOLUME21ISSUE2VERSION1.0.0 Global Journal of Medical Research: B Pharma, Drug Discovery, Toxicology & Medicine Globa l Journal of Medical Research: B Pharma, Drug Discovery, Toxicology & Medicine Volume 2 1 Issue 2 (Ver. 1.0) Open Association of Research Society Global Journals Inc. © Global Journal of Medical (A Delaware USA Incorporation with “Good Standing”; Reg. Number: 0423089) Sponsors:Open Association of Research Society Research. 2021. Open Scientific Standards All rights reserved. Publisher’s Headquarters office This is a special issue published in version 1.0 of “Global Journal of Medical Research.” By ® Global Journals Inc. Global Journals Headquarters 945th Concord Streets, All articles are open access articles distributed under “Global Journal of Medical Research” Framingham Massachusetts Pin: 01701, United States of America Reading License, which permits restricted use. Entire contents are copyright by of “Global USA Toll Free: +001-888-839-7392 Journal of Medical Research” unless USA Toll Free Fax: +001-888-839-7392 otherwise noted on specific articles. Offset Typesetting No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including Global Journals Incorporated photocopy, recording, or any information 2nd, Lansdowne, Lansdowne Rd., Croydon-Surrey, storage and retrieval system, without written permission. Pin: CR9 2ER, United Kingdom The opinions and statements made in this Packaging & Continental Dispatching book are those of the authors concerned. Ultraculture has not verified and neither confirms nor denies any of the foregoing and Global Journals Pvt Ltd no warranty or fitness is implied.
    [Show full text]
  • Region Sjælland
    Identification of DRPs by pharmacists and pharmaconomists performing two types of medication reviews in a Danish hospital setting Oral Communication – 5th PCNE Working Symposium 2016, Hillerød, Denmark Trine R. H. Nielsen Thank you to Laura V. M. Lech The Danish hospital pharmaconomist • Pharmaconomists have a 3-year trainee education in pharmaceuticals and health care. • Region Zealand Hospital Pharmacy has 2,5 pharmaconomist per clinical pharmacist. • Pharmaconomists perform medication management (PMM) daily on all bed units. • PMM consists of top-up service, logistics and prescription reviews. • Prescription review is defined as: A technical review of each drug prescription with focus on prescribing and dispensing within the hospital formulary*. • Each pharmaconomist perform 50-100 prescription review each day. * Kjeldsen, LJ. et al (2014). Ugeskrift for laeger, 176(24). Purpose How many and what kind of DRPs are identified during the daily prescription reviews? How are these DRPs compared to a clinical pharmacist medication review? Method - Setting Næstved Hospital: • Rural non-university hospital with 11 departments and 38 wards (bed-units and out-patient clinics) • The 14 bed-units were invited to participate • 8 bedunits participated in the 3-week study • Each unit received an Clinical Pharmacist Service for 1 week. Participants: • Adults • All newly admitted patients • Had one or more prescriptions Method - Intervention Pharmaconomist Medicine Management Prescription Review PCNE Type 1 Clinical Pharmacist Service Medication Review PCNE Type 2b Baseline Review PCNE “Type 1” (PCNE workshop 2013) Method – Intervention tools The different reviews was made on the same group of patients simultaneously, but separately. RDTC: Regional Drug and Therapeutics Committee Method – Outcome measure • Number of DRPs In total and per patient • Type of DRPs Using the PCNE DRP Classification V6.2 • Severity of DRPs Using a classification ranging from S.1 (serious adverse events) to S.5 (unlikely to affect the patient)* *Dutton, Karen, et al.
    [Show full text]
  • The Community Pharmacy Advising COPD Patients About Medical
    The Community Pharmacy advising COPD patients about medical nutrition by Theresia Treschow-Kühl, Pharmaconomist, Master of Divinity & Master of Education and HR Aabenraa Løve Apotek, Aabenraa, Denmark Conclusion: Introduction: Weight loss: The weight loss was prevalent in the survey, was the expected In Denmark it is estimated 320.000 Danes have COPD, but only about 50 % result - but it was not! The information and knowledge about COPD should have been diagnosed. The Danish population is 5,6 million, it is a stagger- have given a result in the survey, that most of the costumers would have ing 7,5 % of the population suffer from COPD. In Denmark about 300.000 experiences a loss og weight. But loss og weight was not prevalent in the suffer from astma which is 7 % of the Danish population (The Danish Soci- survey - only 30 % of the costumers had lost weight, and 25 % had actu- ety of Lung disease). ally gained weight. In Denmark we have a strategy concerning Asthma Inhaling Instruction. The The factors can be many: Danish Board of Health awards the pharmacy a certain payment for every 1. A small survey - costumers are met at the counter, not costumers who Asthma Inhaling Instruction. are more or less housebound. The instructions of Astma Inhaling devizes are used by Astma and COPD 2. The costumers understanding when the loss of weight was an issue. patients, and the pharmacies have a certified advisory scheme concerning 3. Is it the “New normal” that counts when costumers who have been di- the use af Inhaling devizes. The Pharmacy already are in contact with the agnosed with COPD for more than 4 years 9 out of 14 either maintain costumers have established a dialogue with the patients.
    [Show full text]
  • PHARMACISTS International Appeal to Stop 5G on Earth and in Space
    International Appeal to Stop 5G on Earth and in Space PHARMACISTS ALGERIA Ghania Laouar, pharmacy, student at university of BATNA 2 -BATNA-ALGERIA, Batna, Algeria ARGENTINA Fedra Elena Lecumberry, Farmacéutica Nacional, Director Técnico, Rincón de Los Sauces, Neuquén Paula Mora, Pharmacist, Buenos Aires, Buenos Aires Andrea Vaquero , Universitario, Farmacéutico Hospital Tornu, Bolivar, Buenos Aires AUSTRALIA emma collyns, Diploma of Pharmacy, Pharmacist, Minyama, QLD Jeffrey Cox, Batchelor of Pharmacy, Pharmacist, Melbourne, Vicky Taru Crane, Pharmacist, ULLADULLA, NSW Elise Dafinis, Melbourne, Victoria Xaviere Desmet, Sydney, Nsw George Dimaris, Bachelor of Pharmacy, Sydney, New South Wales Didi Hounslow, Walkerville, SA Ana Jezdik, Law, Pharmacy, Perth, Western Australia noel keogh, b.pharmacy univ qld aust; m.pharm studies univ qld aust ; public policy studies kennedy school of govt harvard mass.usa, armidale, new south wales John Laird, Bachelor of Pharmacy, Postgrad study in Nutrition, Psychology, Philosophy and Exercise Physiology, Pharmacist, Gold Coast, Queensland karl landers, BSc.Pharmacy, pharmacy, brookvale, NSW Vicky Melissas, Bachelor of pharmacy, Pharmacist, Melbourne, Victoria Judy Miller, Adelaide, South Australia George Papadopoulos, Kellys Plains John Ralph, Gosford, NSW PATRICK THORNTON, PHARMACIST, NUTRITIONIST, INVENTOR, OAK FLATS, NSW Natalia Varakina, Bachelor of Pharmacy, Sydney Ingrid Waite, Sydney, NSW Jess White, Doonan, Queensland AUSTRIA Susanne Artacker, Mag. pharm., Pharmacist, Vienna Margit Drack, Drogistin,
    [Show full text]
  • Danish Reaction to Challenges When Working in Pharmacies Or Training to Be a Pharmaconomist During COVID-19 Christina Durinck1, Elsebeth Hagen2
    Pharmacy Education (2020) 20(2) 102 - 105 https://doi.org/10.46542/pe.2020.202.102105 COVID-19 SPECIAL COLLECTION EDITORIAL Moving online and keeping a distance: Danish reaction to challenges when working in pharmacies or training to be a pharmaconomist during COVID-19 Christina Durinck1, ElseBeth Hagen2 1The Danish Association of Pharmaconomists, Denmark 2The Pharmacological Association, Denmark Correspondence This article describes the workforce and educational challenges faced by Christina Durinck pharmaconomists in Denmark as a consequence of the first wave of the The Danish Association of Pharmaconomists COVID-19 pandemic. In Danish pharmacies, pharmaconomists make up the Ramsingsvej 30 majority of the staff. They hold a higher level of qualification than the general 2500 ValBy European pharmacy technician, more comparable to that of a Bachelor’s degree. Denmark In the community pharmacies, pharmaconomists worked long hours and faced [email protected] new questions and a change in behaviour by the public due to the pandemic. An emergency agreement Between The Danish Association of Pharmaconomists and the Association of Danish Pharmacies made flexible planning possible, and guidelines with recommendations meant that most community pharmacies ended up introducing safety measures. In hospitals, pharmaconomists were directly engaged in deciding which kinds of medicine to stock up on to help the COVID-19 patients as they were admitted to hospital. A high level of cooperation and the slashing of red tape made things run relatively smooth. The training of pharmaconomist students went online in spring of 2020, as did exams. It required planning, as did the return to physical school activities as well as CPE in the autumn of 2020.
    [Show full text]
  • Denmark V2 2012 2 the “PHARMINE Survey of European Higher Education Institutions Delivering Pharmacy Education & Training – DENMARK” Was Produced By
    Pharmacy education & training in DDEENNMMAARRKK 22001122 –– VVeerrssiioonn 22 . PHARMINE (PHARMacy education IN Europe) is a project funded by the European Commission (LLL programme, Erasmus). Its aims and objectives are to survey the present state of pharmacy education and training in Europe, and on the basis of this survey, formulate recommendations for new competence curricula for pharmacy education and training in the EU. A model for pharmacy ieducation and training for candidate member states and other countries will be proposed. The opportunities for a quality assurance and accreditation scheme for EU pharmacy courses will be investigated. PHARMINE will take into account two important issues, (i) the EU directive 2005/36/EC on the recognition of professional qualifications and, (ii) the Bologna declaration. PHARMINE will focus both on recommendations for core education and training and for activities such as industrial and hospital pharmacy. The PHARMINE consortium consists of universities which are members of the European Association of Faculties of Pharmacy (EAFP) and EU partner associations representing community, hospital of industrial pharmacy, together with the European Pharmacy Students’ Association and other interested bodies. In order to reach the objectives of the PHARMINE project, a work-plan was set up and divided into 7 work- packages (WP). The aims and objectives of PHARMINE WP7 are to: 1. Survey European higher education institutions (HEIs) 2. Produce a databank of pharmacy education and training courses in Europe leading to core pharmacist qualifications and to qualifications required for industrial and hospital pharmacy 3. Survey to what extent the “Bologna” (based on the principles enumerated in the Bologna declaration) and the “Sectoral profession” (based on 2005/36/EC) models for pharmacy education and training are compatible.
    [Show full text]
  • Public Health and Patient Care Aspects in Pharmacy Education and Pharmacists’ Role in National Public Health Programs in India
    Clinical Pharmacy Group: Social Pharmacy Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy University of Helsinki Public Health and Patient Care Aspects in Pharmacy Education and Pharmacists’ Role in National Public Health Programs in India Siva Prasada Reddy Maddirala Venkata ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Pharmacy of the University of Helsinki, for public examination in Auditorium Athena, Siltavuorenpenger 3 A, on Friday 19 May 2017, at 12 noon. Helsinki 2017 Supervisors Professor Marja Airaksinen, PhD Clinical Pharmacy Group: Social Pharmacy Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy, University of Helsinki Helsinki, Finland Proprietor Pharmacist Peter Kielgast, PhD Taastrup Pharmacy Taastrup Hovedgade 60 2630 Taastrup, Denmark Pre-examiners Professor B. Suresh Vice-Chancellor, Jagadguru Sri Shivarathreeshwara University and President, Pharmacy Council of India JSS Medical Institutions Campus Sri Shivarathreeshwara Nagara Mysuru – 570 015, Karnataka, India Dr. T. V. Narayana Director, Vikas Institute of Pharmaceutical Sciences Nidigatla village, Korukonda Mandal, Near Airport Rajahmundry, East Godavari Dist Andhra Pradesh – 533103, India Opponent Fernando Fernandez-Llimos, Ph.D., PharmD., M.B.A. Assistant Professor, Department of Social Pharmacy University of Lisbon, Portugal © Siva Prasada Reddy Maddirala Venkata 2017 ISBN 978-951-51-3169-0 (paperback) ISBN 978-951-51-3170-6 (PDF) Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis Helsinkiensis ISSN 2342-3161 (print) ISSN 2342-317x (online) University of Helsinki, Finland 2017 ABSTRACT Pharmacies are convenient for most people to get to and there is no need for an appointment to see pharmacist which makes them natural first port of call1 healthcare providers in the society.
    [Show full text]